OKLAHOMA CITY, Sept. 24, 2024 /PRNewswire/ — Wheeler Bio, Inc., an agile contract development and manufacturing organization (CDMO), announced today an expansion in capabilities through the licensing of ATUM’s innovative miFuc™ platform designed for expression of recombinant proteins…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.